FDA says VMaxx Rx contains hidden drug ingredient

The Food and Drug Administration (FDA) is advising consumers not to purchase or use “VMaxx Rx,” a product for sexual enhancement sold on various websites, including www.vmaxxrx.com.

FDA laboratory analysis confirmed that “VMaxx Rx” contains the undeclared ingredient sulfoaildenafil.   Sulfoaildenafil is an analog of sildenafil, an FDA approved prescription drug used to treat Erectile Dysfunction (ED). This drug may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels.  Men with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

Consumers should stop using this product immediately and throw it away. Consumers who have experienced any negative side effects should consult a health care professional as soon as possible.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Note: This notification is to inform the public of a growing trend of products marketed as dietary supplements or conventional foods with hidden drugs and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building, and are often represented as being “all natural.” FDA is unable to test and identify all products marketed as dietary supplements on the market that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories.

Please refer to the links below for more information:

 VMaxx Rx (back label)  VMaxx Rx

Contact FDA

Posted in Men's Health | Leave a comment

Marathoner death risk remains low during or soon after race: American Journal of Sports Medicine

Even though hundreds of thousands more people finished grueling 26.2 mile marathons in the United States in 2009 compared to a decade earlier, a runner’s risk of dying during or soon after the race has remained very low — about .75 per 100,000, new Johns Hopkins research suggests. Men, however, were twice as likely to die as women.

“It’s very dramatic when someone dies on the course, but it’s not common,” says Julius Cuong Pham, M.D., Ph.D., an associate professor of emergency medicine and anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine, and leader of the study published online in The American Journal of Sports Medicine. “There are clearly many health benefits associated with running. It doesn’t make you immune, but your risk of dying from running a marathon is very, very low.”

Pham and his colleagues found that between 2000 and 2009, 28 people died during or in the 24 hours following, a marathon, most of them men. Half of those who died were over age 45, and all but one in the over-45 group died of heart disease. For younger runners, the cause of death varied widely and included cardiac arrhythmia and hyponatremia, the latter owing to drinking excessive amounts of water.

Marathons have long been considered the pinnacle of endurance sports, but they have become wildly popular in recent years. Pham and colleagues looked at statistics from approximately 300 marathons per year and found that the number of finishers increased dramatically between 2000 and 2009, from 299,018 to 473,354. The researchers said they believe the recent increase in marathon popularity is partially because of increasing awareness of the health benefits gained from regular exercise.

Numerous studies have linked exercise to better physical and mental health, and to longevity, Pham says. Similarly, marathon running has been associated with decreased risks of hypertension, high cholesterol and diabetes. People who run regularly have been found to have lower rates of all-cause mortality and disability.

With so many more people participating, Pham says he expected to find that the pace of marathons would have slowed over time, but the average finishing time also stayed steady at roughly four hours and 35 minutes.

One limitation of the study, however, is that there is no easily available access to data on the number of people who drop out of the races without finishing, which may have artificially kept average finishing times higher.

Pham, a three-time marathoner himself, cautions that people should not think that marathon training or running is risk-free. He noted that studies have shown the yearly incidence of injury in people training for marathons to be as high as 90 percent, with the vast majority of injuries damaging the musculoskeletal system.

###

Other Johns Hopkins researchers who contributed to this study include Simon C. Mathews, M.D.; David L. Narotsky, B.A.; David L. Bernholt, B.S.; Matthew Vogt, B.S.; Yu-Hsiang Hsieh, Ph.D.; and Peter J. Pronovost, M.D., Ph.D.

Source

Posted in Exercise: Marathons, Fitness: Running, Sports Medicine | 1 Comment

Physician burnout stats are staggering

More posts about stress

FORT LAUDERDALE, FL–(Marketwire – May 16, 2012) – While physicians tell patients to exercise and de-stress, they are not practicing this healthy advice themselves. A survey from Weatherby Healthcare finds more than 82 percent of those surveyed forgo personal activities such as hobbies, working out, and family time because of busy work schedules.

Like the patients they serve, doctors need adequate time to cope with stressors from work in order to be effective on the job. A top way to de-stress is exercise and a whopping 44 percent of physicians say they don’t have time to do so because of busy work schedules. Other lifestyle choices doctors face result in:

  • 43 percent don’t go on vacations
  • 38 percent miss out on family time
  • 41 percent would like more time for volunteer work
  • 42 percent forgo their hobbies

Many physicians feel they must retire, close their practice, or even change careers to achieve a work-life balance and avoid burnout. By becoming a locum tenens, a physician that fills an open position in a medical facility for a specific period of time, practitioners can create a more flexible schedule based on where and how often they would like to work. With 94 percent of physicians saying they would like a more accommodating schedule while maintaining credibility and regular patients, this could be a viable option.

“It’s alarming that forty-six percent of physicians don’t feel a flexible work schedule is possible in the medical field,” said Pat Kennedy, President of Weatherby Healthcare. “Locum tenens have the opportunity to make their own schedule based on how often and where they would like to work, giving them control to create a work/life balance, improving patient care and their quality of work.”

For physicians, experiencing new environments is not only educational, but enjoyable. In fact, 45 percent of physicians are interested in working in a different city or town, and 54 percent of those physicians would make the move for an adventure. Traveling for full time physicians can be very limited due to their demanding work schedules.

Locum tenens provide a solution for physicians trying to achieve a better work/life balance. Practitioners are able to create a flexible schedule based on where and how often they would like to work. This balance results in better quality care and patient satisfaction.

“This country is losing the experience, skill and wisdom of senior physicians because of burnout,” said Dr. Duane Gainsburg, neurosurgeon with Weatherby Healthcare. “In private practice, I wasn’t able to deliver the best care I was capable of due to all the distractions and missed professional opportunity. By moving my career into the locum tenens venue, these are issues of the past.”

Survey Methodology

The Weatherby Healthcare Survey was conducted by Wakefield Research among 1,000 U.S. physicians ages 25+, between February 3rd and February 17th 2012, using an email invitation and an online survey. Results of any sample are subject to sampling variation. A full methodology is available.

About Weatherby Healthcare

Weatherby Healthcare is an elite staffing firm recognized for its superior Red Ribbon Service. Established in 1995, the company specializes in providing quality locum tenens physicians, physician assistants and nurse practitioners to the nation’s top hospitals and healthcare facilities. It is also a winner of numerous industry and workplace awards. To see why, visit www.weatherbyhealthcare.com.

More posts about stress

Posted in Health Care: Costs, Health Care: Medical Errors, Human Behavior, Human Behavior: Fatigue, Human Behavior: Habits, Human Behavior: Happiness, Human Behavior: Stress, Human Behavior: Work Ethic | Leave a comment

Virtual exercise partners boost performance, motivation: Annals of Behavioral Medicine

A competent, virtual exercise partner can boost motivation and improve team performance

A new study, testing the benefits of a virtual exercise partner, shows that the presence of a moderately more capable cycling partner boosts motivation to stick to an exercise program. The work by Brandon Irwin and colleagues, from Michigan State University in the US, is published online in Springer’s journal, Annals of Behavioral Medicine.

For many people, lack of motivation is a barrier to achieving both the recommended amount and intensity of exercise. Using the principles of group exercise, which is known to increase people’s motivation to stick to an exercise program, the researchers investigated whether a virtually present partner would influence participants’ motivation to exercise for longer.

A total of 58 young women, recruited from university-based physical activity courses, took part in the experiment and exercised on a stationary bike on six separate days, including one training session. They were split into three groups. The first group exercised independently alongside a virtual person. The second group also exercised alongside a virtual person but this time they worked as a team, and the performance of the team was determined by the weakest link i.e. the one who stopped exercising first. The third group cycled alone.

At the start of the experiment, the women in groups 1 and 2 were assigned a ‘virtually present partner’ – also a female – for the ride and were told that their partner would be riding at the same time they were, on a similar bike in another lab. The women ‘met’ their partners via a pre-recorded video-chat, and were told that their partner’s performance was moderately better than their own. During the exercise sessions, participants were able to track their partner’s progress by watching the partner ride, on what looked like a live feed but was in fact a recording.

All students rode a video-game exercise bike for as long as they felt comfortable. They were then asked to rate their intention to exercise again, how well they felt they had done, and how tired they felt. The researchers measured how hard they had worked.

Overall, exercising with a virtually present partner improved performance on the cycling task: Participants cycled for longer when working alongside a more capable partner than when exercising alone. Across sessions, those women who exercised as part of a team cycled, on average, two minutes longer than those who exercised independently with a partner (22 versus 20 minutes), and twice as long as those who exercised without a partner (22 versus 11 minutes).

In terms of motivation, there was a marked decline in intent to exercise among those who cycled on their own. In contrast, those who cycled with a virtual partner reported no decline in motivation to exercise.

The authors conclude: “Being able to more than double one’s performance is a substantial gain for those trying to increase their physical activity. These results are encouraging and suggest that the gains we observed over six hour-long sessions could be sustained on a longer-term program of exercise. This may be of particular value in future efforts to help people meet physical activity recommendations.”

  • Full bibliographic information: Irwin BC et al (2012). Aerobic exercise is promoted when individual performance affects the group: a test of the Köhler motivation gain effect. Annals of Behavioral Medicine; DOI 10.1007/s12160-012-9367-4

Source

Posted in Commercial Fitness Industry, Corporate Wellness, Exercise, Exercise: Capacity, Exercise: Incentives, Human Behavior: Motivation, Mobile Health | Leave a comment

More elderly falls? Or just more reporting of same?

More posts about elders and falls

The recent dramatic increase in the fall death rate in older Americans is likely the effect of improved reporting quality, according to a new report from the Johns Hopkins Center for Injury Research and Policy. The report finds the largest increase in the mortality rate occurred immediately following the 1999 introduction of an update to the International Classification of Diseases (ICD-10), suggesting a major change in the way deaths were classified. Several research studies, including one by the report’s authors, found that rates of fatal falls among seniors had risen as much as 42 percent between 2000 and 2006. The results are published in the May-June issue of Public Health Reports.

“We had been perplexed by the sudden increase because neither the nonfatal fall rate nor the fall-hospitalization rate increased significantly,” said Susan P. Baker, MPH, a professor with the Johns Hopkins Center for Injury Research and Policy, part of the Johns Hopkins Bloomberg School of Public Health. “By ruling out these variables, we found that a change in how the underlying cause of death gets reported explains much of the widely-reported increase.”

As it turns out, the largest increase was seen in the coding subgroup “other falls on the same level,” which refer to when an individual falls on the same surface they are standing or walking on; such falls generally do not result in injury that is immediately life-threatening.

“Death following a minor injury from a fall typically involves the elderly and usually occurs weeks or months after the fall as the result of pneumonia or other complications. Previously, many of these deaths were coded as the illness rather than the fall,” said study author Guoqing Hu, PhD, faculty with the Central South University School of Public Health in China. “However after ICD-10 went into effect in 1999, the rate of deaths from this type of fall jumped, suggesting a major change in death certification practices.”

Each year, one in three older adults in the U.S. falls, making falls the leading cause of injury deaths for older Americans. The annual direct and indirect cost of fall injuries is expected to reach $55 billion by 2020. Accurate interpretation of recent trends is critical for understanding the effect of ongoing measures designed to prevent fall injuries in the elderly.

“Falls in older adults are indeed a major public health problem, and this report should not suggest otherwise,” concluded Baker. “In fact, it’s likely that for some time we’ve been under-reporting just how many older Americans die as a result of a fall, a hypothesis supported by international comparisons. Additional research and resources are needed to address this problem.”

###

Support for this research was provided by the Faculty Development Award from the China Medical Board of NY, the 2009 New Century Scholar Support Program of the Ministry of Education of China, and the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.

Details for this study can be accessed by Hu G, Baker SP. An explanation for the recent increase in the fall death rate among older Americans: a subgroup analysis. Public Health Rep. 2012 May;127(3):275-81.

For more news from the Johns Hopkins Bloomberg School of Public Health, visit www.jhsph.edu/publichealthnews or follow us on Facebook at www.facebook.com/JohnHopkinsSPH or on Twitter at www.twitter.com/JohnsHopkinsSPH.

Source

More posts about elders and falls

Posted in Elder Care: Falls | Leave a comment

A form of breast cancer is effectively treated with chemical found in celery, parsley

More breast cancer posts

Apigenin, a natural substance found in grocery store produce aisles, shows promise as a non-toxic treatment for an aggressive form of human breast cancer, following a new study at the University of Missouri. MU researchers found apigenin shrank a type of breast cancer tumor that is stimulated by progestin, a synthetic hormone given to women to ease symptoms related to menopause.

“This is the first study to show that apigenin, which can be extracted from celery, parsley and many other natural sources, is effective against human breast cancer cells that had been influenced by a certain chemical used in hormone replacement therapy,” said co-author Salman Hyder, the Zalk Endowed Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center.

In the study, Hyder and his colleagues implanted cells of a deadly, fast-growing human breast cancer, known as BT-474, into a specialized breed of mouse. Some of the mice were then treated with medroxyprogesterone acetate (MPA), a type of progestin commonly given to post-menopausal women. A control group did not receive MPA.

Later one group of MPA-treated mice was treated with apigenin. Cancerous tumors grew rapidly in the mice which did not receive apigenin. In the apigenin-treated mice, breast cancer cell growth dropped to that of the control group, and the tumors shrank.

“We don’t know exactly how apigenin does this on a chemical level,” Hyder said. “We do know that apigenin slowed the progression of human breast cancer cells in three ways: by inducing cell death, by inhibiting cell proliferation, and by reducing expression of a gene associated with cancer growth. Blood vessels responsible for feeding cancer cells also had smaller diameters in apigenin-treated mice compared to untreated mice. Smaller vessels mean restricted nutrient flow to the tumors and may have served to starve the cancer as well as limiting its ability to spread.”

The mice in Hyder’s study were injected with apigenin. In the future, apigenin injections could be a safe alternative or supplement to the highly toxic chemotherapy drugs now in use.

“Chemotherapy drugs cause hair-loss, extreme fatigue and other side effects,” Hyder said. “Apigenin has shown no toxic side-effects even at high dosages. People have eaten it since pre-history in fruits and vegetables.”

Finding funding for clinical testing of apigenin in humans may be difficult, according to Hyder.

“Clinical trials of apigenin with humans could start tomorrow, but we have to wait for medical doctors to carry out that next step,” Hyder said. “One problem is, because apigenin doesn’t have a known specific target in the cancer cell, funding agencies have been reticent to support the research. Also, since apigenin is easily extracted from plants, pharmaceutical companies don’t stand to profit from the treatment; hence the industry won’t put money into studying something you can grow in your garden.”

The research team included Benford Mafuvadze, doctoral student in biomedical sciences; Yanyun Liang, research scientist Dalton Cardiovascular Research Center; Cynthia Besch-Williford, associate professor of veterinary pathobiology; and Xu Zhang, visiting researcher at the Dalton Cardiovascular Research Center.

The research was recently published online in the journal Hormones and Cancer.

For more information about related MU research:

Source

More breast cancer posts

Posted in Cancer: Breast, Nutrition is Medicine, Nutrition: Food: Celery | Leave a comment

Pancreatic cancer: early biomarker identified

More pancreatic cancer posts

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention.  The paper will be published May 15 in Cancer Research.

Pancreatic ductal adenocarcinoma, or PDAC, is the fourth-leading cause of cancer-related death.  Newly diagnosed patients have a median survival of less than one year, and a 5-year survival rate of only 3 to 5 percent. Therefore, biomarkers that can identify early onset of PDAC and which could be viable drug targets are desperately needed.

“We found that a kinase called PEAK1 is turned on very early in pancreatic cancer,” said first author Jonathan Kelber, PhD, a postdoctoral researcher in the UCSD Department of Pathology and Moores Cancer Center.  “This protein was clearly detected in biopsies of malignant tumors from human patients – at the gene and the protein levels – as well as in mouse models.”

PEAK1 is a type of tyrosine kinase – an enzyme, or type of protein, that speeds up chemical reactions and acts as an “on” or “off” switch in many cellular functions.  The fact that PEAK1 expression is increased in human PDAC and that its catalytic activity is important for PDAC cell proliferation makes it an important candidate as a biomarker and therapeutic target for small molecule drug discovery.

In addition to showing that levels of PEAK1 are increased during PDAC progression, the scientists found that PEAK1 is necessary for the cancer to grow and metastasize.

“PEAK1 is a critical signaling hub, regulating cell migration and proliferation,” said Kelber. “We found that if you knock it out in PDAC cells, they form significantly smaller tumors in preclinical mouse models and fail to metastasize efficiently.”

The research team, led by principal investigator Richard Klemke, PhD, UCSD professor of pathology, studied a large, on-line data base of gene expression profiles to uncover the presence of PEAK1 in PDAC.  These findings were corroborated at the protein level in patient biopsy samples from co-investigator Michael Bouvet, MD, and in mouse models developed by Andrew M. Lowy, MD, both of the UCSD Department of Surgery at Moores Cancer Center.

While many proteins are upregulated in cancers of the pancreas, there has been limited success in identifying candidates that, when inhibited, have potential as clinically approved therapeutics. However, the researchers found that inhibition of PEAK1-dependent signaling sensitized PDAC cells to existing chemotherapies such as Gemitabine, and immunotherapies such as Trastuzumab.

“Survival rates for patients with pancreatic cancer remain low,” said Bouvet. “Therefore, earlier detection and novel treatment strategies are very important if we are going to make any progress against pancreatic cancer.  Since current therapies are often ineffective, our hope is that the findings from this research will open up a new line of investigation to bring a PEAK1 inhibitor to the clinic.”

Additional contributors to the study include Theresa Reno, Sharmeela Kaushal, Cristina Metildi,Tracy Wright, Konstantin Stoletov, Jessica M. Weems, Frederick D. Park, Evangeline Mose, UC San Diego; Yingchun Wang, Chinese Academy of Science, Beijing; and Robert M. Hoffman, UC San Diego and AntiCancer, Inc., San Diego.

The study was supported by the National Institutes of Health.

Source

More pancreatic cancer posts

Posted in Cancer: Pancreatic | Leave a comment

Arthritis may be predicted earlier because of newly discovered biomarker test

More arthritis posts

More than 27 million adults currently suffer from osteoarthritis, which is the most common form of arthritis. In the past, doctors have been unable to diagnose patients with arthritis until they begin to show symptoms, which include joint pain and stiffness.  By the time these symptoms are present, it is often too late for preventive and minimally invasive treatment options to be effective.  Now, a research team from the University of Missouri’s Comparative Orthopaedic Laboratory has found a way to detect and predict arthritis before patients begin suffering from symptoms.

James Cook, a researcher from the MU College of Veterinary Medicine and the William C. and Kathryn E. Allen Distinguished Professor in Orthopaedic Surgery, along with MU researchers Bridget Garner, Aaron Stoker, Keiichi Kuroki, Cristi Cook, and Prakash Jayabalan, have developed a test using specific biomarkers that can accurately determine if a patient is developing arthritis as well as predict the potential severity of the disease. The test can be run off of a single drop of fluid from a patient’s joint, which is obtained with a small needle similar to drawing blood.

“With this biomarker test, we can study the levels of specific proteins that we now know are associated with osteoarthritis,” Cook said. “Not only does the test have the potential to help predict future arthritis, but it also tells us about the early mechanisms of arthritis, which will lead to better treatments in the future.”

In their study published in the Journal of Knee Surgery, the MU researchers report that they developed the test by analyzing the joints of dogs that suffer from arthritis. Veterinarians predict that 20 percent of middle-aged dogs and 90 percent of older dogs have osteoarthritis in one or more joints.  Since canine joints operate similarly to the joints of humans, Cook says the test is being adapted to human patients.

“This test has already shown early usefulness for allowing us to monitor how different treatments affect the arthritic joints in people,” Cook said. “With further validation, this test will allow doctors to adjust and fine tune treatments to individual patients. Also, being able to tell patients when they are at a high risk for developing arthritis will give doctors a strong motivational tool to convince patients to take preventive measures including appropriate exercise and diet change.”

The biomarker test is currently available for licensing and is in the process of gaining FDA approval.

This study is a result of collaboration through Mizzou Advantage, a program that focuses on four areas of strength at MU: food for the future, media of the future, one health/one medicine, and sustainable energy. The goals of Mizzou Advantage are to strengthen existing faculty networks, create new networks and propel Mizzou’s research, instruction and other activities to the next level. The Mizzou Advantage was created to increase MU’s visibility, impact and stature in higher education, locally, statewide, nationally and around the world.

Source

More arthritis posts

Posted in Arthritis | Leave a comment

Patient-targeted molecular therapies gets its own journal space

New section in journal of translational medicine: patient-targeted molecular therapies

Adrian Bot and Francesco Chiappelli

For all author emails, please log on.

Journal of Translational Medicine 2012, 10:92 doi:10.1186/1479-5876-10-92

Published: 15 May 2012

Abstract (provisional)

This Editorial announces a new section in the Journal of Translational Medicine: Patient-Targeted Molecular Therapies.

This section is dedicated to the dissemination of targeted molecular therapies in context of patient centered outcomes research and evidence-based clinical decisions.

The focus on patient-targeted molecular therapies – spanning small molecules and biomolecules alike – stems from the unprecedented growth in this arena.

This is consonant with the overall objective of the Journal of Translational Medicine, which seeks out to expand firmly to other vast areas of medicine in the domain of translational science, viewed here as the transaction between translational research and translational effectiveness. As we inaugurate this new section in Journal of Translational Medicine, with its mission described in detail in this Editorial, we invite interested scientists to submit their work for publication.

The complete article is available as a provisional PDF.

The fully formatted PDF and HTML versions are in production.

Posted in Personalized Medicine, Science Updates | Leave a comment

How fructose slows the brain, hampering memory and learning and how omega-3s can turn it around

More fructose and omega-3s posts

A new UCLA study is the first to show how a diet steadily high in fructose slows the brain, hampering memory and learning — and how omega-3 fatty acids can counteract the disruption. The peer-reviewed Journal of Physiology publishes the findings in its May 15 edition.

“Our findings illustrate that what you eat affects how you think,” said Fernando Gomez-Pinilla, a professor of neurosurgery at the David Geffen School of Medicine at UCLA and a professor of integrative biology and physiology in the UCLA College of Letters and Science. “Eating a high-fructose diet over the long term alters your brain’s ability to learn and remember information. But adding omega-3 fatty acids to your meals can help minimize the damage.”

While earlier research has revealed how fructose harms the body through its role in diabetes, obesity and fatty liver, this study is the first to uncover how the sweetener influences the brain.

The UCLA team zeroed in on high-fructose corn syrup, an inexpensive liquid six times sweeter than cane sugar, that is commonly added to processed foods, including soft drinks, condiments, applesauce and baby food. The average American consumes more than 40 pounds of high-fructose corn syrup per year, according to the U.S. Department of Agriculture.

“We’re not talking about naturally occurring fructose in fruits, which also contain important antioxidants,” explained Gomez-Pinilla, who is also a member of UCLA’s Brain Research Institute and Brain Injury Research Center. “We’re concerned about high-fructose corn syrup that is added to manufactured food products as a sweetener and preservative.”

Gomez-Pinilla and study co-author Rahul Agrawal, a UCLA visiting postdoctoral fellow from India, studied two groups of rats that each consumed a fructose solution as drinking water for six weeks. The second group also received omega-3 fatty acids in the form of flaxseed oil and docosahexaenoic acid (DHA), which protects against damage to the synapses — the chemical connections between brain cells that enable memory and learning.

“DHA is essential for synaptic function — brain cells’ ability to transmit signals to one another,” Gomez-Pinilla said. “This is the mechanism that makes learning and memory possible. Our bodies can’t produce enough DHA, so it must be supplemented through our diet.”

The animals were fed standard rat chow and trained on a maze twice daily for five days before starting the experimental diet. The UCLA team tested how well the rats were able to navigate the maze, which contained numerous holes but only one exit. The scientists placed visual landmarks in the maze to help the rats learn and remember the way.

Six weeks later, the researchers tested the rats’ ability to recall the route and escape the maze. What they saw surprised them.

“The second group of rats navigated the maze much faster than the rats that did not receive omega-3 fatty acids,” Gomez-Pinilla said. “The DHA-deprived animals were slower, and their brains showed a decline in synaptic activity. Their brain cells had trouble signaling each other, disrupting the rats’ ability to think clearly and recall the route they’d learned six weeks earlier.”

The DHA-deprived rats also developed signs of resistance to insulin, a hormone that controls blood sugar and regulates synaptic function in the brain. A closer look at the rats’ brain tissue suggested that insulin had lost much of its power to influence the brain cells.

“Because insulin can penetrate the blood–brain barrier, the hormone may signal neurons to trigger reactions that disrupt learning and cause memory loss,” Gomez-Pinilla said.

He suspects that fructose is the culprit behind the DHA-deficient rats’ brain dysfunction. Eating too much fructose could block insulin’s ability to regulate how cells use and store sugar for the energy required for processing thoughts and emotions.

“Insulin is important in the body for controlling blood sugar, but it may play a different role in the brain, where insulin appears to disturb memory and learning,” he said. “Our study shows that a high-fructose diet harms the brain as well as the body. This is something new.”

Gomez-Pinilla, a native of Chile and an exercise enthusiast who practices what he preaches, advises people to keep fructose intake to a minimum and swap sugary desserts for fresh berries and Greek yogurt, which he keeps within arm’s reach in a small refrigerator in his office. An occasional bar of dark chocolate that hasn’t been processed with a lot of extra sweetener is fine too, he said.

Still planning to throw caution to the wind and indulge in a hot-fudge sundae? Then also eat foods rich in omega-3 fatty acids, like salmon, walnuts and flaxseeds, or take a daily DHA capsule. Gomez-Pinilla recommends one gram of DHA per day.

“Our findings suggest that consuming DHA regularly protects the brain against fructose’s harmful effects,” said Gomez-Pinilla. “It’s like saving money in the bank. You want to build a reserve for your brain to tap when it requires extra fuel to fight off future diseases.”

The UCLA study was funded by the National Institute of Neurological Disorders and Stroke. Gomez-Pinilla’s lab will next examine the role of diet in recovery from brain trauma.

The UCLA Department of Neurosurgery is committed to providing the most comprehensive patient care through innovative clinical programs in minimally invasive brain and spinal surgery; neuroendoscopy; neuro-oncology for both adult and pediatric brain tumors; cerebrovascular surgery; stereotactic radiosurgery for brain and spinal disorders; surgery for movement disorders such as Parkinson’s disease; and epilepsy surgery. For 20 consecutive years, the department has been ranked among the top 10 neurosurgery programs in the nation by U.S. News & World Report.

Source

More fructose and omega-3s posts

Posted in Brain, Nutrition: Fructose, Nutrition: Omega-3 | Leave a comment

Dietary supplements can increase cancer risk: Journal of the National Cancer Institute

Beta-carotene, selenium and folic acid – taken up to three times their recommended daily allowance, these supplements are probably harmless. But taken at much higher levels as some supplement manufacturers suggest, these three supplements have now been proven to increase the risk of developing a host of cancers.

“It’s not that these nutrients are toxic – they’re essential and we need them, but we need them in a certain balance,” says Tim Byers, MD, MPH, professor of epidemiology at the Colorado School of Public Health and associate director for prevention and control at the University of Colorado Cancer Center.

Byers is senior author of a commentary recently published in the Journal of the National Cancer Institute that discusses the clinical and policy implications of the increased cancer risk from high dose dietary supplements.

“We have a window into less than half of the biology of what these nutrients are doing,” Byers says. “We say generalized things about them, calling them an antioxidant or an essential mineral, but true biology turns out to be more complex than that. The effects of these supplements are certainly not limited to the label we give them. And, as we’ve seen, sometimes the unintended effects include increased cancer risk.”

Currently the FDA regulates dietary supplements as food, but, as Byers and colleagues suggest, supplements, especially at high doses, are more accurately described as inhabiting a mid-ground between food and drugs. Like drugs, supplement ingredients are biologically active – sometimes for better and sometimes for worse.

“We need to do a better job as a society in ensuring that the messages people get about value versus risk is accurate for nutritional supplements,” Byers says. “My conclusion is that taking high doses of any particular nutrient is more likely to be a bad thing than a good thing.”

###

This work was supported by the National Institutes of Health and the National Cancer Institute.

Source

Related: American Cancer Society Complete Guide to Complementary & Alternative Cancer Therapies

Posted in Cancer, Nutrition: Beta-Carotine, Nutrition: Selenium, Nutrition: Vitamins and Minerals: Folic Acid | Leave a comment

Congressman praises Obama administration for Alzheimer’s efforts

WASHINGTON, May 15, 2012 /PRNewswire-USNewswire/ – Congressman Chaka Fattah (D-PA), the leading Democratic appropriator for government-sponsored brain research, issues this statement upon release of the Obama Administration’s plan for fighting Alzheimer’s Disease:

“The human and social cost of Alzheimer’s Disease upon our nation exceeds even the dollar figure, which is $200 billion this year and rising. The Obama Administration is to be commended for their continued commitment toward research funding focused on developing cures and treatments for the debilitating disease. The Administration priority to prevent and effectively treat Alzheimer’s by 2025 is indeed a critical expression of the national will for an all-out assault on this and other brain diseases.”

Congressman Fattah is author of the Fattah Neuroscience Initiative, enacted with bipartisan support last December to declare neuroscience research a national priority to be coordinated by the White House. Fattah is Ranking Democrat on the House Appropriations Committee’s Subcommittee on Commerce, Justice, Science and Related Agencies, which oversees funding for much of government-sponsored research.

SOURCE Office of Congressman Chaka Fattah

Source: PR Newswire (http://s.tt/1bTM8)

Posted in Alzheimer's | Leave a comment

Diabetics could number 53,000,000 soon in US, says new research

The Diabetes 2025 Model for the U.S. projects a continuous and dramatic increase in the diabetes epidemic and makes it possible to estimate the potential effects of society-wide changes in lifestyle and healthcare delivery systems. Predictions for individual states and population subgroups are highlighted in an article published in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Population Health Management website at http://www.liebertpub.com/pop.

“Diabetes is now a national security issue as it threatens all aspects of our nation’s well-being,” says Journal Editor-in-Chief David B. Nash, MD, MBA, Dean, Jefferson School of Population Health (Philadelphia, PA).

Based on their Diabetes 2025 Model, William Rowley, MD and Clement Bezold, PhD, Institute for Alternative Futures (Alexandria, VA), project that diabetes (mainly type 2 diabetes) will affect 53.1 million Americans by 2025, an increase of 64% from 2010. Their model can also be used to estimate the benefit of changes in lifestyle and specific interventions in reducing the burden of diabetes, according to the article “Creating Public Awareness: State 2025 Diabetes Forecasts.”

###

About the Journal

Population Health Management is an authoritative peer-reviewed journal published bimonthly in print and online that reflects the expanding scope of health care management and quality. The Journal delivers a comprehensive, integrated approach to the field of population health and provides information designed to improve the systems and policies that affect health care quality, access, and outcomes, thereby improving the health of an entire population. Comprising peer-reviewed original research papers, clinical research, and case studies, the content includes a broad range of chronic diseases such as cardiovascular disease, cancer, chronic pain, diabetes, depression, and obesity, as well as focusing on various aspects of prevention and wellness. Tables of content and a sample issue may be viewed on the Population Health Management website at http://www.liebertpub.com/pop. Population Health Management is the Official Journal of The Care Continuum Alliance.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Women’s Health, Diabetes Technology & Therapeutics, and Childhood Obesity. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc. website at http://www.liebertpub.com.

Source

Posted in Diabetes, Obesity, Public Health | Leave a comment

Looks matter more than reputation when it comes to trusting people with our money

Our decisions to trust people with our money are based more on how they look then how they behave, according to new research from the University of Warwick.

In a paper recently published in the PLoS One journal, researchers from Warwick Business School, the University College London and Dartmouth College, USA, carried out a series of experiments to see if people made decisions to trust others based on their faces.

They found people are more likely to invest money in someone whose face is generally perceived as trustworthy, even when they are given negative information about this person’s reputation.

The team used a computer algorithm to create a set of 20 pairs of faces at opposing ends of the trustworthiness scale. This computer software modifies the apparent trustworthiness of faces by altering their features. The researchers were able to experimentally manipulate the unfakeable features (those related to shape of the face) that make a face look trustworthy or untrustworthy. These 40 faces were then used in a series of trust games with human participants.

Each volunteer was given a sum of money and told they could invest any part of the amount in a trustee whose face appeared on the screen. Any amount they invested would be tripled and volunteers were told it was then up to the trustee to decide how much to send back to them. Thus participants had an incentive to invest only in trustees who could be expected to return more than the invested amount.

The researchers found that 13 out of 15 participants invested more, on average, in the trustworthy identities. In a second experiment, the researchers gave the volunteers information about whether the trustees had good or bad histories. Even with this inside information, the average amount invested in those who looked ‘trustworthy’ was 6% higher.

Dr Chris Olivola from the University of Warwick’s Warwick Business School said: “Trustees with good and bad histories benefitted equally from trustworthy-looking facial features. The temptation to judge strangers by their faces is hard to resist. Trustworthiness is one of the most important traits for social and economic interactions and our study examines whether people take potentially costly actions in line with their face-based trustworthiness judgments.

“It seems we are still willing to go with our own instincts about whether we think someone looks like we can trust them.”

###

‘Unfakeable Facial Configurations Affect Strategic Choices in Trust Games with or without Information about Past Behaviour’, Constantin Rezlescu, Brad Duchaine, Christopher Y Olivola, Nick Chater. PLoS ONE, 7 (3):e34293.

Source

Posted in Human Behavior: Perception, Human Behavior: Trust | Leave a comment

Older American’s Month: A Presidential Proclamation

Presidential Proclamation — Older Americans Month, 2012

OLDER AMERICANS MONTH, 2012
- – - – - – -
BY THE PRESIDENT OF THE UNITED STATES OF AMERICA
A PROCLAMATION

America endured great trials and heralded defining triumphs over the course of the 20th century, and the men and women who saw us through that time remain among our Nation’s greatest assets. Through their guiding wisdom, enduring love of family, and inspiring commitment to country, older Americans continue to steer and enhance our national life.

Our seniors make countless contributions as active participants in communities across America. From our parks and schools to our faith and service organizations, the generosity and talents of active seniors augment our children’s education, bring our families together, and strengthen the fabric of our society. This year’s theme for Older Americans Month, “Never Too Old to Play,” celebrates the accomplishments of older Americans and encourages them to find even more ways to stay engaged. May 7 through May 11, 2012, is also Senior Corps Week, when we celebrate the service of the over 300,000 Senior Corps volunteers. Individuals interested in information on local volunteer opportunities can visit www.SeniorCorps.gov.

As we honor the achievements and ongoing contributions of older Americans, my Administration is working with States, territories, and tribes to provide them with support to stay healthy, independent, and engaged. We remain deeply committed to strengthening Medicare, protecting Social Security, enhancing Older Americans Act programs, and implementing the historic Affordable Care Act, which provided more than 32 million seniors with at least one free preventive service or wellness visit last year and helped over 5 million save more than $3.2 billion on prescription drug costs in 2010 and 2011. The Department of Health and Human Services recently awarded more than $1.3 billion in grants to ensure the health and independence of America’s older adults, including $20 million focused on fitness, chronic disease self-management, and medication management. And the Consumer Financial Protection Bureau is safeguarding older Americans from unscrupulous financial schemes that threaten their fiscal security.

Our seniors have devoted their entire lives to building the future their children and grandchildren deserve. During Older Americans Month, we celebrate their successes and recommit to supporting them as they shape America’s next great generation.

NOW, THEREFORE, I, BARACK OBAMA, President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim May 2012 as Older Americans Month. I call upon all Americans of all ages to acknowledge the contributions of older Americans during this month and throughout the year.

IN WITNESS WHEREOF, I have hereunto set my hand this first day of May, in the year of our Lord two thousand twelve, and of the Independence of the United States of America the two hundred and thirty-sixth.

BARACK OBAMA

Source

Editor’s note: This was dated May 1 but was sent out via email from the “USA.gov team” on May 15.

Posted in Elder Care, Health Care: Costs | Leave a comment